Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus, Cetuximab and Capecitabine in Metastatic Pancreatic Cancer
NCT01077986Phase 2Completed
- Sponsor
- University of Amsterdam
- Start
- Aug 2009
- Primary completion
- Aug 2010
- Modality
- Antibody Conjugates, Monoclonal Antibodies, DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus, cetuximab, capecitabine, sponsored by University of Amsterdam. Started Aug 2009; status: completed.
02
Drugs
everolimuscetuximabcapecitabine
Beyond the preview
Go deeper on NCT01077986.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01077986.